RIVA-DM: Effectiveness and Safety of Rivaroxaban vs. Warfarin in Nonvalvular Atrial Fibrillation and Diabetes Mellitus: Analysis of Electronic Health Record Data

20/08/2020
02/07/2024
EU PAS number:
EUPAS36634
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

21449_Study Protocol_V1.0_2020-08-19_Redacted

English (679.75 KB - PDF) View document
Updated protocol

21449_Study Protocol_V2.0_2020-11-09_Redacted

First published: 22/02/2024
English (1.14 MB - PDF) View document
Study results
Study results

21449_EU PAS Abstract_Redacted_V1.0_2021-11-05

English (542.81 KB - PDF) View document
Study report
Study report

21449_Study Report_Redacted_V1.0_2021-11-05

English (867.86 KB - PDF) View document
Other information